Swedbank AB Acquires 200,000 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Swedbank AB grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 14.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,629,602 shares of the medical device company’s stock after purchasing an additional 200,000 shares during the quarter. Swedbank AB owned approximately 0.82% of Cooper Companies worth $149,809,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Public Sector Pension Investment Board grew its stake in Cooper Companies by 71.7% in the 2nd quarter. Public Sector Pension Investment Board now owns 7,590 shares of the medical device company’s stock valued at $663,000 after buying an additional 3,170 shares in the last quarter. MBB Public Markets I LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $1,261,000. Magnolia Capital Advisors LLC purchased a new stake in shares of Cooper Companies in the second quarter worth about $211,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Cooper Companies by 23.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,868 shares of the medical device company’s stock valued at $163,000 after acquiring an additional 354 shares during the period. Finally, Wallace Advisory Group LLC bought a new stake in Cooper Companies during the 2nd quarter worth approximately $290,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded down $0.26 during trading on Wednesday, hitting $98.25. The company had a trading volume of 47,755 shares, compared to its average volume of 1,402,073. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market capitalization of $19.61 billion, a P/E ratio of 50.39, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99. The stock has a 50 day simple moving average of $95.94 and a 200 day simple moving average of $99.55.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the business posted $0.87 EPS. Cooper Companies’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently commented on COO. Citigroup reduced their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.